The combination of preclinical studies and retrospective assessment of human melanoma samples for chemokine receptor expression have shed light on a finely controlled process that notably involves CCR4, CCR6, CCR7, CCR9, CCR10, CXCR3, CXCR4, and CXCR7 expression. Here, ACKR3 is linked to melanoma.